Corbus Pharmaceuticals Holdings Inc. – Filings and Transcripts

NASDAQ: CRBP
Share price (9/30/26): $6.82
Market cap (9/30/26): $132 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Ownership Filter

Ra Capital Management, L.P.

Nicacio Leonardo Viana

Citadel Advisors LLC

Saxena Nishant C

News Filter

Announces Positive Topline Data From CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Reports Q2 2026 Financial Results and Provides a Corporate Update

Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer

Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission